共 152 条
[2]
Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): a randomized trial
[J].
DIABETES OBESITY & METABOLISM,
2015, 17 (03)
:268-275
[6]
Aleppo G, 2017, J ENDOCR SOC, V1, P1445, DOI 10.1210/js.2017-00388
[7]
Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial
[J].
BRITISH MEDICAL JOURNAL,
2002, 325 (7367)
:746-749
[8]
[Anonymous], 2017, FDA Drug Safety Communication: FDA review results in new warnings about using general anesthetics and sedation drugs in young children and pregnant women
[10]
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
[J].
LANCET DIABETES & ENDOCRINOLOGY,
2017, 5 (05)
:355-366